Astrana Health, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 09/30/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.2B | $2.0B | $1.4B | $1.1B | — |
| Operating income | $78.5M | $89.3M | $84.6M | $104.3M | — |
| Interest expense | $49.9M | $33.1M | $16.1M | $7.9M | — |
| Pretax income | $39.6M | $80.8M | $89.8M | $86.6M | — |
| Income tax expense | $15.5M | $30.9M | $32.0M | $40.9M | — |
| Net income | $22.5M | $43.1M | $60.7M | $45.2M | — |
| Balance Sheet | |||||
| Cash and equivalents | $429.5M | $288.5M | $293.8M | $288.0M | — |
| Current assets | $863.3M | $638.5M | $461.5M | $428.1M | $445.8M |
| Total assets | $2.2B | $1.4B | $933.4M | $966.2M | $954.9M |
| Current liabilities | $615.3M | $365.6M | $218.7M | $148.6M | — |
| Total liabilities | $1.7B | $840.7M | $522.6M | $407.7M | $410.4M |
| Total debt | $1.1B | $438.1M | $282.0M | $207.3M | — |
| Stockholders' equity | $779.3M | $712.7M | $614.2M | $542.6M | $504.4M |
| Cash Flow Statement | |||||
| Cash from operations | $114.6M | $52.2M | $68.2M | $82.1M | — |
| Depreciation and amortization | $45.7M | $27.9M | $17.7M | $17.5M | — |
| Stock-based compensation | $38.6M | $34.5M | $22.0M | $16.1M | — |
| Capital expenditure | $10.1M | $8.0M | $28.5M | $22.9M | — |
| Free cash flow | $104.5M | $44.2M | $39.7M | $59.2M | — |
| Dividends paid | $7.9M | $4.0M | $62.1M | $14.0M | — |
| Share repurchases | $25.6M | $900,000 | $10.2M | $9.2M | — |
| Impairments | $0 | $0 | $0 | $0 | — |
Shares outstanding 55.7M · Free float 52.8%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.